Boothbay Fund Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-52,296
| Closed | -$9.61M | – | 2182 |
|
|
2021
Q2 | $9.61M | Buy |
52,296
+25,110
| +92% | +$4.61M | 0.31% | 45 |
|
|
2021
Q1 | $4.16M | Buy |
27,186
+12,579
| +86% | +$1.92M | 0.16% | 96 |
|
|
2020
Q4 | $2.28M | Buy |
+14,607
| New | +$2.28M | 0.08% | 191 |
|
|
2020
Q2 | – | Sell |
-3,100
| Closed | -$278K | – | 1061 |
|
|
2020
Q1 | $278K | Buy |
+3,100
| New | +$278K | 0.02% | 499 |
|
|
2019
Q4 | – | Sell |
-16,037
| Closed | -$1.57M | – | 986 |
|
|
2019
Q3 | $1.57M | Buy |
16,037
+14,249
| +797% | +$1.4M | 0.14% | 155 |
|
|
2019
Q2 | $234K | Buy |
+1,788
| New | +$234K | 0.02% | 482 |
|
|
2017
Q2 | – | Sell |
-2,364
| Closed | -$287K | – | 825 |
|
|
2017
Q1 | $287K | Buy |
2,364
+502
| +27% | +$60.9K | 0.05% | 370 |
|
|
2016
Q4 | $228 | Sell |
1,862
-254
| -12% | -$31 | 0.05% | 484 |
|
|
2016
Q3 | $259K | Buy |
+2,116
| New | +$259K | 0.06% | 361 |
|